Fate Therapeutics, Inc (FATE) Stock Price

2.45 ▼ -0.06 (-2.39%)
Open: 2.51 Vol: 1.46M Day's range: 2.39 - 2.555 Jul 31, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
FATE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL NEUTRAL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.45▼ 2.46▼ 2.45▼ 2.41▲ 2.73▼
MA10 2.46▼ 2.45▼ 2.46▼ 2.52▼ 2.47▼
MA20 2.46▼ 2.46▼ 2.41▲ 2.74▼ 2.01▲
MA50 2.45▼ 2.39▲ 2.42▲ 2.44▲ 1.51▲
MA100 2.46▼ 2.44▲ 2.63▼ 1.94▲ 1.62▲
MA200 2.42▲ 2.66▼ 2.64▼ 1.57▲ 3.96▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.003▼ 0.008▲ -0.068▼ 0.039▲
RSI 42.600▼ 51.657▲ 52.365▲ 46.168▼ 56.746▲
STOCH 30.000     66.052     35.431     17.909▼ 64.774    
WILL %R -83.333▼ -66.667     -56.410     -76.331▼ -38.806    
CCI -164.394▼ -10.792     5.769     -56.558     23.072    
Latest Filters Detected On FATE
MA $FATE Price Crossed Above MA(50) Set Alert
MA $FATE Price Crossed Above MA(7) Set Alert
Fate Therapeutics, Inc News
Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
Monday, July 06, 2026 01:30 AM
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Tuesday, June 02, 2026 01:06 PM
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent ...
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
Tuesday, October 14, 2025 05:01 AM
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent ...
FATE historical stock data
date open high low close volume
31/07/26 2.51 2.555 2.39 2.45 1,459,168
30/07/26 2.36 2.55 2.345 2.51 1,698,291
29/07/26 2.33 2.43 2.26 2.36 1,075,505
28/07/26 2.42 2.42 2.25 2.32 1,851,858
27/07/26 2.49 2.52 2.39 2.43 564,084
24/07/26 2.52 2.545 2.40 2.41 1,044,435
23/07/26 2.57 2.61 2.47 2.52 1,637,234
22/07/26 2.80 2.82 2.57 2.58 1,499,137
21/07/26 2.84 2.86 2.78 2.83 1,143,679
20/07/26 2.76 2.89 2.74 2.795 1,456,549
Quote Details
52wk Low:0.91
52wk High:3.23
Vol:1.46M
Avg Vol(3m):86.7M
1Y Chng:+104.17%
1M Chng:+17.22%
Add to Watch List
More Information
Index US Composite
Market Cap. 292.56M